Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J Sickler

Filgrastim and Alemtuzumab (Campath-1h) for Refractory Chronic Lymphocytic Leukemia

Cancer Research

English

Related publications

Remission of Chronic Inflammatory Demyelinating Polyneuropathy After Alemtuzumab (Campath 1H)

Journal of Neurology, Neurosurgery and Psychiatry

English

First-Line Treatment of Chronic Lymphocytic Leukemia: Role of Alemtuzumab

OncoTargets and Therapy

English

Refractory Chronic Lymphocytic Leukemia – New Therapeutic Strategies

English

The Use of Low-Dose Alemtuzumab in Pretreated B-Cell Chronic Lymphocytic Leukemia

Cancer Research

English

Analysis of Treatment Options for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Value in Health

Occupational Health

English

FDA Drug Approval Summary: Alemtuzumab as Single-Agent Treatment for B-Cell Chronic Lymphocytic Leukemia

Cancer Research

English

R-Dhap Is Effective in Fludarabine-Refractory Chronic Lymphocytic Leukemia

Cancer Research

English

Chronic Lymphocytic Leukemia

Current Opinion in Hematology

English

Azacitidine in Fludarabine-Refractory Chronic Lymphocytic Leukemia: A Phase II Study

Clinical Lymphoma, Myeloma and Leukemia

Cancer Research

English